One Global Service Provider Adjusts Share Issue Price for Matrix Labs Acquisition

Total non-cash consideration remains at Rs 39.54 crore despite pricing adjustments per share.
7,06,068 shares will be issued to settle the 51% stake purchase in two Matrix Labs entities.

Reader Takeaway: The deal remains value-neutral for the company, ensuring regulatory compliance without impacting the original acquisition scope.

What just happened

One Global Service Provider Ltd has signed an addendum to its Share Purchase Agreements dated September 18, 2026. The move follows guidance from BSE Limited to align the preferential issue price of shares with SEBI (ICDR) regulations. The company is acquiring a 51% stake in Matrix Labs Diagnocare Private Limited and Matrix Labs Private Limited.

Why this matters

The amendment ensures the acquisition process adheres to current market regulations, preventing potential regulatory friction. By adjusting the issue price to Rs 560.13 for MLDPL and Rs 558.99 for MLPL, the company brings the deal into full regulatory alignment while maintaining the agreed-upon total consideration.

Terms of the Addendum

The transaction involves the issuance of 7,06,068 equity shares at a face value of Rs 10 each. The addendum explicitly updates the pricing and share count while confirming that all other original terms of the acquisition remain unchanged. The sellers, Mr. Suresh and Ms. Nithya S, will receive the adjusted share allotments as non-cash consideration. No new governance rights or special veto powers were granted through this addendum.

Risks to watch

Investors should monitor the integration of these diagnostics-focused entities into the company’s existing operations. While management stated there is no adverse impact on business, the successful scaling of these new assets will be key to realizing the intended expansion in the healthcare services sector.

What to track next

Watch for the formal allotment of these equity shares and subsequent filings confirming the completion of the share transfer. Further updates on the operational performance of the newly acquired Matrix Labs entities will be relevant for gauging the acquisition's long-term value.